会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 21. 发明公开
    • A DEVICE FOR REPAIR SURGERY OF RUPTURED TENDONS, COMPRISING A THERAPEUTIC AGENT FOR STIMULATING REGROWTH
    • 一种用于修复破裂的肌腱手术的装置,包括用于刺激复发的治疗剂
    • EP3202428A1
    • 2017-08-09
    • EP16178874.0
    • 2016-07-11
    • Universität Zürich
    • The designation of the inventor has not yet been filed
    • A61L27/18A61L27/54
    • A61L27/18A61L27/54A61L2430/10C08L67/04A61L2300/414
    • A device for repair surgery of cylindrical organs, particularly of ruptured tendons, is configured as a tubular sheath (T) made of a mesh of elastic fibers formed by electrospinning a biocompatible and biodegradable polymer. The tubular sheath has a Young elasticity modulus of about 0.1 to about 4 MPa and a strain at break of about 50 to about 1'000 %, and it has a first wall surface and a second wall surface substantially parallel thereto, with said first wall surface being comparatively smooth (W S ) and said second wall surface being comparatively rough (W R ). According to the invention, the elastic fibers comprise first fibers consist of polymer in neat form and second fibers consist of polymer with an admixture of a therapeutic agent for stimulating regrowth processes of a predetermined cylindrical organ. The tubular sheath comprises a first tubular region adjacent to the first wall and a second tubular region adjacent to the second wall, said first tubular region being formed of said first fibers and said second tubular region being formed of said second fibers.
    • 用于圆柱形器官,特别是破裂腱的修复手术的装置被配置为由弹性纤维网制成的管状护套(T),所述弹性纤维网通过静电纺丝生物相容且可生物降解的聚合物而形成。 所述管状护套具有约0.1至约4MPa的杨氏弹性模量和约50至约1'000%的断裂应变,并且其具有第一壁表面和基本平行于其的第二壁表面,所述第一壁 表面比较光滑(WS)并且所述第二壁表面比较粗糙(WR)。 根据本发明,弹性纤维包括由纯净聚合物形成的第一纤维和由聚合物构成的第二纤维以及用于刺激预定圆柱形器官再生长过程的治疗剂混合物。 管状护套包括与第一壁相邻的第一管状区域和与第二壁相邻的第二管状区域,所述第一管状区域由所述第一纤维形成,所述第二管状区域由所述第二纤维形成。
    • 23. 发明公开
    • COLLAGEN-BASED THERAPEUTIC DELIVERY SYSTEMS
    • 基于胶原蛋白的治疗性递送系统
    • EP3185922A1
    • 2017-07-05
    • EP15835953.9
    • 2015-08-27
    • Purdue Research Foundation Office of Technology Commercialization
    • VOYTIK-HARBIN, Sherry
    • A61L31/04
    • A61L27/24A61K9/0024A61K9/19A61K38/18A61K47/42A61L27/54A61L2300/414A61L2300/604A61L2400/06
    • A collagen-based therapeutic delivery device includes an insoluble synthetic collagen-fibril matrix comprising a polymerization product of soluble oligomeric collagen or a polymerization product of a mixture of soluble oligomeric collagen with one or more type of non-oligomeric soluble collagen molecules, such as, for example, soluble telocollagen and/or soluble atelocollagen, and an active agent dispersed throughout the collagen-fibril matrix or within a portion of the collagen-fibril matrix. A pre-matrix composition includes an aqueous solution including soluble collagen-fibril building blocks and an active agent in the aqueous solution. The soluble collagen-fibril building blocks include soluble oligomeric collagen or a mixture of soluble oligomeric collagen with non-oligomeric soluble collagen molecules. The building blocks are operable to self-assemble into a macromolecular synthetic collagen-fibril matrix in the absence of an exogenous cross-linking agent. Methods of making and using the pre-matrix composition and the device are also provided.
    • 基于胶原的治疗递送装置包括不溶性合成胶原 - 原纤维基质,其包含可溶低聚胶原的聚合产物或可溶低聚胶原与一种或多种非寡聚可溶性胶原分子的混合物的聚合产物, 例如,可溶性端粒胶原和/或可溶性整链端胶原,以及分散在整个胶原 - 原纤维基质中或部分胶原 - 原纤维基质内的活性剂。 预基质组合物包括含有可溶性胶原 - 原纤结构单元和水溶液中的活性剂的水溶液。 可溶性胶原 - 原纤结构单元包括可溶性低聚胶原或可溶低聚胶原与非寡聚可溶性胶原分子的混合物。 在不存在外源交联剂的情况下,构建块可操作以自组装成大分子合成胶原 - 原纤维基质。 还提供了制造和使用预制基质组合物和装置的方法。